6118 — Austar Lifesciences Share Price
0.000.00%
Last trade - 00:00- HK$425.44m
- HK$777.06m
- CNY1.76bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.51 | ||
| Price to Tang. Book | 0.54 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.22 | ||
| EV to EBITDA | 46.01 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -3.06% | ||
| Return on Equity | -3.91% | ||
| Operating Margin | -1.7% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 1,049.02 | 1,295.98 | 2,015.03 | 2,156.87 | 1,763.73 | n/a | n/a | 16.65% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +296.06 | +214.45 | +206.49 | -6.94 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Austar Lifesciences Limited is principally engaged in the provision of integrated engineering solutions to pharmaceutical manufactures and research institutes and the manufacture and distribution of pharmaceutical equipment and consumables in China. The Company operates its business through six segments: liquid and bioprocess system segment, clean room and automation control and monitoring system segment, powder and solid system segment, good manufacturing practice (GMP) compliance service segment, life science consumables segment and distribution and agency of pharmaceutical equipment segment.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 9th, 2014
- Public Since
- November 7th, 2014
- No. of Employees
- 1,610
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 512,582,000
- Address
- Rooms 2010-2013,, SHANGHAI
- Web
- https://www.austar.com.cn/
- Phone
- Auditors
- PricewaterhouseCoopers
Upcoming Events for 6118
Similar to 6118
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
What is the Austar Lifesciences share price?
As of Today at 19:03 UTC, shares in Austar Lifesciences are trading at HK$0.83. This share price information is delayed by 15 minutes.
How has the Austar Lifesciences share price performed this year?
Shares in Austar Lifesciences last closed at HK$0.83 and the price had moved by -55.38% over the past 365 days. In terms of relative price strength the Austar Lifesciences share price has underperformed the FTSE Developed Asia Pacific Index by -56.66% over the past year.
What are the analyst and broker recommendations for Austar Lifesciences?
There is no consensus recommendation for this security.
What is the Austar Lifesciences dividend yield?
Austar Lifesciences does not currently pay a dividend.
Does Austar Lifesciences pay a dividend?
Austar Lifesciences does not currently pay a dividend.
When does Austar Lifesciences next pay dividends?
Austar Lifesciences does not currently pay a dividend.
How do I buy Austar Lifesciences shares?
To buy shares in Austar Lifesciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Austar Lifesciences?
As of the previous close price of HK$0.83, shares in Austar Lifesciences had a market capitalisation of HK$425.44m.
Where are Austar Lifesciences shares listed?
Here are the trading details for Austar Lifesciences:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 6118
What kind of share is Austar Lifesciences?
Based on an overall assessment of its quality, value and momentum Austar Lifesciences is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Austar Lifesciences share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Austar Lifesciences share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Austar Lifesciences. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -66.26%.
As of the last closing price of HK$0.83, shares in Austar Lifesciences were trading -56.76% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Austar Lifesciences PE Ratio?
The Austar Lifesciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.83.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Austar Lifesciences?
We do not have data on Austar Lifesciences' directors